COVID-19’s far-reaching effects from lung to liver
30 November 2021Using single-cell sequencing technology, A*STAR scientists have identified a rare population of liver cells susceptible to damage from SARS-CoV-2 infections.
ARCHIVES
136 results for "2021"
Success in the sciences
29 November 2021A*STAR’s steady investments in R&D and talent create the ideal conditions for impactful science, says its Chief Executive Officer Frederick Chew.
Immune secrets of the symptom-free
26 November 2021Unique immune responses shield some COVID-19 patients from the disease’s worst effects.
Boxing in the coronavirus
23 November 2021A new, cost-effective barrier enclosure protects healthcare workers by effectively containing airborne viral particles from COVID-19 patients.
The dark side of green plastics
19 November 2021Mapping the life cycle of biodegradable polymers can help manufacturers make data-driven decisions on the most sustainable production practices.
Confessions of a shape-shifting virus
17 November 2021Contrary to popular belief, a new A*STAR study shows that HIV mutations are far from random, emerging at specific locations at specific rates.
A three-in-one sustainable, self-healing coating
11 November 2021Next-generation self-healing polymers use eco-friendly building blocks and manufacturing processes, providing superior durability and longevity to the materials they coat.
When antibiotics make good yeasts go bad
9 November 2021Broad-acting antibiotics can disrupt the gut microbiome and create the perfect conditions for potentially life-threatening yeast infections to flourish.
Cracking the code of long COVID
5 November 2021Elevated levels of inflammatory factors may be linked to persistent COVID-19 symptoms, researchers find.
Keeping the beat of life
3 November 2021A protein in cilia called CFAP53 is responsible for the distinct beat patterns during embryonic development, researchers say.
A rare glimpse into the pancreas’ origins
1 November 2021Induced pluripotent stem cells have helped researchers map the role of the RFX6 gene in a rare congenital disorder known as Mitchell-Riley Syndrome.
AI makes stem cells less unpredictable
28 October 2021A*STAR researchers have created the first machine learning model for predicting clinical outcomes of stem cell therapies in patients with cartilage disorders.
Flipping the switch on gut inflammation
26 October 2021A newly-discovered role for an immune regulator in T cells may help unravel the molecular basis of inflammatory bowel disease and serve as a promising therapeutic target.
Page
